Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.

Susana MongeAyelén Rojas-BenedictoCarmen OlmedoElisa Martín-MerinoClara MazagatosAurora LimiaMaría José SierraAmparo LarrauriMiguel A Hernán

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Our results suggest that, over a month after administration, a second dose of mRNA vaccine increases protection against SARS-CoV-2 reinfection with the Omicron variant among individuals with single-dose vaccination and previously infected with another variant.

Keyphrases

sars cov
respiratory syndrome coronavirus
randomized controlled trial
binding protein
systematic review
copy number
dna methylation
genome wide